DNAprint Genomics (DNAG)

[dr frudaky]

Blue


I have and my opinion still stands. I want to read what you have stated from the happy managers, all of whom have been all too reticent to disclose anything of substance to the shareholders which could enhance shareholder value. Perhaps there is nothing really visible and tangible for achieving that objective? As many pumpers have stated here, time will tell.

We can revisit the resulting consequences of that IPO, if and when it is realized.

JMHO

dr f